Ribavirin

Especificaciones

36791-04-5Número CAS

636-825-3Número CE

1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamideNombre IUPAC

C8H12N4O5Fórmula química

244.2 g/molPeso molecular

ribavirin; 36791-04-5; Tribavirin; Rebetol; Virazole; Copegus; Vilona; Ribamidil; Ribasphere; Ribavirine; Viramid; RTCA; Ribavirina; Varazid; Ribavirinum; Cotronak; 1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide; ICN-1229; Virazid; Ribavirin Mylan; Ribavirin Teva; 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide; Ribavirin BioPartners; SCH 18908; DTXSID8023557; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide; Ribavirin Teva Pharma B.V.; NSC-163039; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide; CHEBI:63580; 49717AWG6K; ribofluranosyl carboxamide; 1H-1,2,4-Triazole-3-carboxamide, 1-beta-D-ribofuranosyl-; SCH-18908; DTXCID603557; Ribovirin; Viramide; NSC 163039; NSC163039; Ribavarin; ICN 1229; Ribapak; ICN1229; 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-1,2,4-triazole-3-carboxamide; 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-1H-1,2,4-triazole-3-carboxamide; RefChem:6200; J05AP01; 1-Beta-D-ribofuranosyl-1,2,4-triazolo-3-carboxamide; 1-beta-d-ribofuranosyl-1h-1,2, 4-triazole-3-carboxamide; 636-825-3; Ribamide; Ribavirine [INN-French]; Ribavirinum [INN-Latin]; Ribavirina [INN-Spanish]; MFCD00058564; 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-1,2,4-triazole-3-carboxamide; RBV; Ribamidyl; 1-(beta-D-ribofuranosyl)-1H-1,2,4-triazole-3-carboxamide; Rebetron; Ribavirin Capsules; Rebretron; Virazide; 1H-1,2,4-Triazole-3-carboxamide, 1-.beta.-D-ribofuranosyl-; Ribav; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,2,4-triazole-3-carboxamide; 1-ss-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide; RTC; Ravanex; Ribacine; C-Virin; DRG-0028; Ribasphere (TN); Virazole (TN); SMR000058315; Copegus (TN); Rebetol (TN); HSDB 6513; SR-01000076112; BRN 0892462; Ribavirvin; UNII-49717AWG6K; VirustazCotronak; Tribavirin;; Ribamidil;; Virazide;; Virazole;; s2504; Viramid;; Viratek;; Virazid;; Ribavirin CRS; Vilona;; Ribavirin [USAN:USP:INN:BAN]; NCGC00015904-02; 66510-90-5; Ribavirin, antiviral; CAS-36791-04-5; RG-964; Ribavirin (Copegus); Ribavirin (Standard); Ribavirin (Copegus)?; Ro-20-9963; Spectrum_001826; 4pb1; RIBAVIRIN [INN]; RIBAVIRIN [JAN]; RIBAVIRIN [MI]; RIBAVIRIN [HSDB]; RIBAVIRIN [USAN]; Prestwick3_000993; Spectrum3_001876; Spectrum4_001252; Spectrum5_002075; RIBAVIRIN [VANDF]; R-964; Epitope ID:768752; RIBAVIRIN [MART.]; R 9644; RIBAVIRIN [USP-RS]; RIBAVIRIN [WHO-DD]; SCHEMBL3727; 1-.beta.-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide; CHEMBL1643; Lopac0_001063; Ribavirin 100 microg/mL in Acetonitrile:Methanol; BSPBio_001085; BSPBio_003352; KBioGR_001804; KBioSS_002331; RIBAVIRIN [EMA EPAR]; AA-504/07617051; cid_37542; MLS000028486; MLS002222317; DivK1c_000782; SPECTRUM1503938; Ribavirin (JP18/USP/INN); BPBio1_001195; GTPL6842; orb1225184; orb1310388; orb3140076; RIBAVIRIN [ORANGE BOOK]; 1,2,4-Triazole-3-carboxamide, 1-beta-D-ribofuranosyl-; 1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide; RIBAVIRIN [EP MONOGRAPH]; HMS502H04; HY-B0434R; KBio1_000782; KBio2_002328; KBio2_004896; KBio2_007464; KBio3_002854; RIBAVIRIN [USP MONOGRAPH]; NINDS_000782; GLXC-05861; HMS2090L15; HMS2094O09; HMS2098G07; HMS2232P07; HMS3263E08; HMS3715G07; Pharmakon1600-01503938; ALBB-038667; HY-B0434; MSK10023; Tox21_110259; Tox21_200967; Tox21_501063; BDBM50154375; CCG-38985; EBC-00633; HB4522; NSC758650; AKOS001715163; Tox21_110259_1; DB00811; GS-3572; LP01063; NR02712; NSC-758650; SDCCGSBI-0051033.P004; IDI1_000782; SMP1_000261; NCGC00090726-01; NCGC00090726-03; NCGC00090726-04; NCGC00090726-05; NCGC00090726-06; NCGC00090726-07; NCGC00090726-08; NCGC00090726-09; NCGC00090726-12; NCGC00090726-14; NCGC00090726-25; NCGC00090726-30; NCGC00258520-01; NCGC00261748-01; 252269-50-4; AS-34178; SY055294; SBI-0051033.P003; AB00430481; EU-0101063; NS00009126; R0077; R3205; EN300-59237; D00423; AB00430481-15; AB00430481-16; AB00430481_17; AB00430481_18; Ribavirin, Antibiotic for Culture Media Use Only; 1-beta-Ribofuranosyl-1,2,4-triazole-3-carboamide; F079125; Q421862; SR-01000721904; Q-201670; SR-01000076112-2; SR-01000076112-3; SR-01000076112-4; SR-01000721904-2; BRD-K60369935-001-02-7; BRD-K60369935-001-15-9; BRD-K60369935-001-18-3; SR-01000076112-11; 1-(beta-D-Ribofuranosyl)-1,2,4-triazole-3-carboxamide; 1-|_-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide; 1-|A-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide; Ribavirin, British Pharmacopoeia (BP) Reference Standard; Z594284196; 1-(beta -D-ribofuranosyl)-1,2,4-triazole-3-carboxamide; Ribavirin, European Pharmacopoeia (EP) Reference Standard; Ribavirin, United States Pharmacopeia (USP) Reference Standard; Ribavirin, Pharmaceutical Secondary Standard; Certified Reference Material; 1-beta-<span class="DL">D</span>-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide; 1-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide; 1-?-D-Ribofuranosyl-1,2,4-triazole-3-carboxamideSinónimos